Research On Optimization Of Financing Structure Of TP Pharmaceutical Company

TP pharmaceutical company as a local focus on fostering and development of the old state-owned pharmaceutical logistics enterprises,since restructuring,its products in the local market share increased year by year,since 2013,the company experienced a rapid growth in sales revenue,due to the global economic downturn and the domestic downtown pressure on the economy is huge,changeable and unstable financial the environment and competitive pressures increase,resulting in a greater impact on the sustainable development of the company's 2013 annual or even a loss in the past two years,although profitable,but the amount of profit and before work.In addition to performance in the sale of part of the weak weak trend,restricting the huge funding gap for the sustainable development of enterprises is more prominent,the enterprise is facing considerable challenges in financing.From the deeper analysis of the source of the problem of financing channels and financing is a major obstacle in front of TP pharmaceutical company,and for a long time,due to the problem of financing structure leads to many factors such as unreasonable is even more urgent problem which can continue to maintain rapid and stable growth trend in the process,this is whether it can to realize the sustainable development,has become the key to enterprise to changqing.Based on the theory of financing structure and the related classical theory,"TP pharmaceutical company" as the business case analysis,firstly,the research background,research significance and methods to be introduced and explained,analyzes the causes of many problems in the financing structure based on the classical theory of the status quo,on the financing structure TP pharmaceutical enterprises currently exist and these problems,finally puts forward the scheme of optimizing the financing structure and the related safeguard measures.Performance of the financing structure cases of companies as the single way of financing,financing costs,high rate of assets and liabilities,financing scale,current liabilities to total debt ratio of odd higher status;the status quo and the enterprise financing structure unreasonable,the development of long-term extensive management mode from quantitative to qualitative change cycle,poor decision-making the lag and constitution is not perfect and so on;the company is currently in the rapid growth of value creation,financing structure problems is bound to cause enterprise leaders attach great importance,this paper aims to study the structure optimization of TP pharmaceutical company financing case of enterprises,to find out a new way for the sustainable development of the enterprise long-term financing structure optimization.